SCHEMBL24186352

SCHEMBL24186352

Fc1ccc(-c2n[nH]c3nnc(-c4ccccc4)c(Cl)c23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.43
▸ MAP2K4 P45985 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ GSK3B P49841 3/20 0.39
▸ HPGD P15428 2/20 0.38
▸ GSK3A P49840 2/20 0.37
▸ ADORA2A P29274 2/20 0.36
▸ MKNK1 Q9BUB5 1/20 0.36
▸ MKNK2 Q9HBH9 1/20 0.36
▸ MAPK14 Q16539 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALPL P05186 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ IDO1 P14902 1/20 0.36
▸ TTK P33981 1/20 0.36
▸ MAPK10 P53779 1/20 0.36
▸ ADORA1 P30542 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13738909 0.91 GSK3B (0.44) ALDH1A1MAP2K4SMN1; SMN2NPSR1GSK3B
SCHEMBL30349192 0.91 GSK3B (0.44) ALDH1A1MAP2K4SMN1; SMN2NPSR1GSK3B
SCHEMBL15655636 0.88 MAP2K4 (0.43) ALDH1A1MAP2K4SMN1; SMN2MEN1KMT2A
SCHEMBL15653909 0.88 MAP2K4 (0.43) ALDH1A1MAP2K4SMN1; SMN2MEN1KMT2A
SCHEMBL15655491 0.87 ADORA2A (0.42) MAP2K4GSK3BHPGDGSK3AADORA2A
SCHEMBL18401301 0.86 GSK3B (0.39) ALDH1A1MAP2K4SMN1; SMN2KMT2ANPSR1
SCHEMBL18513164 0.86 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1
SCHEMBL24186354 0.82 ADORA1 (0.49) ALDH1A1SMN1; SMN2GSK3BHPGDADORA2A
SCHEMBL15685544 0.78 HPGD (0.41) ALDH1A1MAP2K4SMN1; SMN2NPSR1GSK3B
SCHEMBL15656164 0.78 GSK3B (0.41) ALDH1A1SMN1; SMN2GSK3BHPGDGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022011091-A1 TREATMENT OF CANCER, INFLAMMATORY DISEASES AND AUTOIMMUNE DISEASES USHER III INITIATIVE, INC. (US) 2022-01-13 — — WO disclosed
Send feedback